VIALE, PIERLUIGI
 Distribuzione geografica
Continente #
AS - Asia 28.237
NA - Nord America 24.939
EU - Europa 22.204
SA - Sud America 1.902
AF - Africa 1.314
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 78.705
Nazione #
US - Stati Uniti d'America 24.567
SG - Singapore 7.928
CN - Cina 7.238
VN - Vietnam 6.785
IT - Italia 5.936
GB - Regno Unito 4.330
DE - Germania 2.722
NL - Olanda 2.158
HK - Hong Kong 1.917
SE - Svezia 1.889
BR - Brasile 1.329
IN - India 1.234
FR - Francia 1.175
KR - Corea 1.017
RU - Federazione Russa 938
IE - Irlanda 627
FI - Finlandia 530
JP - Giappone 513
UA - Ucraina 396
CI - Costa d'Avorio 373
ZA - Sudafrica 335
AR - Argentina 240
BG - Bulgaria 226
ID - Indonesia 213
TG - Togo 211
CH - Svizzera 204
EE - Estonia 200
CA - Canada 192
AT - Austria 176
PH - Filippine 168
JO - Giordania 167
BD - Bangladesh 153
ES - Italia 133
TH - Thailandia 133
IQ - Iraq 127
MX - Messico 111
PL - Polonia 101
BE - Belgio 95
TW - Taiwan 95
TR - Turchia 93
SC - Seychelles 84
AU - Australia 82
PK - Pakistan 81
NG - Nigeria 80
EC - Ecuador 71
SA - Arabia Saudita 68
CL - Cile 60
RO - Romania 52
CO - Colombia 50
LT - Lituania 46
PE - Perù 44
MY - Malesia 43
IR - Iran 41
PY - Paraguay 40
GR - Grecia 38
UZ - Uzbekistan 36
HR - Croazia 35
MA - Marocco 35
VE - Venezuela 35
PT - Portogallo 30
CD - Congo 27
EG - Egitto 27
TN - Tunisia 26
CZ - Repubblica Ceca 24
AE - Emirati Arabi Uniti 23
DK - Danimarca 23
LB - Libano 23
DZ - Algeria 21
KE - Kenya 18
HU - Ungheria 17
KZ - Kazakistan 17
NP - Nepal 17
RS - Serbia 16
SK - Slovacchia (Repubblica Slovacca) 16
AZ - Azerbaigian 15
IL - Israele 15
AL - Albania 14
UY - Uruguay 14
BO - Bolivia 12
PA - Panama 12
ET - Etiopia 11
LV - Lettonia 10
OM - Oman 10
DO - Repubblica Dominicana 9
AO - Angola 8
BH - Bahrain 8
CY - Cipro 8
EU - Europa 8
HN - Honduras 8
LY - Libia 8
BA - Bosnia-Erzegovina 7
CR - Costa Rica 7
GH - Ghana 7
JM - Giamaica 7
MK - Macedonia 7
AM - Armenia 6
KG - Kirghizistan 6
KH - Cambogia 6
NO - Norvegia 6
SY - Repubblica araba siriana 6
Totale 78.556
Città #
Singapore 5.583
Southend 3.841
Ashburn 3.043
Fairfield 2.256
Hefei 1.984
Hong Kong 1.789
Ho Chi Minh City 1.614
San Jose 1.581
Chandler 1.436
Hanoi 1.386
Santa Clara 1.197
Bologna 1.039
Woodbridge 1.034
Seattle 965
Seoul 931
Wilmington 921
Houston 891
Frankfurt am Main 867
Princeton 803
Cambridge 755
Ann Arbor 735
Beijing 717
Eygelshoven 676
Kerkrade 648
Dublin 621
Dong Ket 612
Boardman 587
Lauterbourg 539
Milan 510
Los Angeles 425
Tokyo 423
Abidjan 373
Dallas 370
Helsinki 363
New York 349
Rome 338
Council Bluffs 331
Nanjing 286
Westminster 255
Da Nang 243
Padova 226
Berlin 220
Lomé 211
Sofia 207
Bengaluru 205
Buffalo 204
Haiphong 199
Redondo Beach 190
San Diego 170
Amman 163
Turin 162
Jinan 161
Florence 159
Chicago 157
Shanghai 156
São Paulo 154
Saint Petersburg 145
Guangzhou 138
Nuremberg 137
Munich 131
Bern 129
Jakarta 126
Redmond 124
Shenyang 114
Bremen 112
Changsha 111
Lappeenranta 103
Des Moines 102
Amsterdam 99
Dearborn 97
Nanchang 93
Naples 91
London 89
Vienna 89
Jacksonville 85
The Dalles 85
Brescia 84
Hebei 84
Brussels 83
Redwood City 76
Verona 73
Hải Dương 72
Zhengzhou 71
Tianjin 70
Biên Hòa 69
Genoa 68
Abeokuta 66
Johannesburg 66
Olalla 66
Rio de Janeiro 66
Falkenstein 65
Orem 65
Jiaxing 64
Phoenix 64
Can Tho 63
Falls Church 63
Tongling 63
Baghdad 62
Hangzhou 62
Modena 62
Totale 50.108
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 1.724
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa ? 955
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases] 928
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 559
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 474
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 403
2017 WSES guidelines on colon and rectal cancer emergencies: Obstruction and perforation 403
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 390
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study. 363
Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence 346
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 342
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 322
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 322
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 314
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 310
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients 308
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 294
Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: Sensitivity and specificity of current guidelines on bone mineral density management 289
Restriction Factors expression decreases in HIV-1 patients after cART 269
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 255
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 253
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 253
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 252
Infections in liver and lung transplant recipients: A national prospective cohort 251
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 250
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 249
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 246
Spinal tuberculosis: Proposed spinal infection multidisciplinary management project (SIMP) flow chart revision 246
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 244
A Case Report of Tolvaptan Therapy for ADPKD Patients with COVID-19. The Need for Appropriate Counselling for Temporary Drug Discontinuation 240
Incidence of hospital-acquired infections due to carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa in critically ill patients in Italy: a multicentre prospective cohort study 240
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 238
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. 238
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 238
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 235
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia 230
Pathological post-mortem findings in lungs infected with SARS-CoV-2 228
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 227
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 226
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 225
Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study 220
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 220
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 219
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 217
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 213
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach 213
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 212
Chagas Disease in a Non-endemic Country: A Multidisciplinary Research, Bologna, Italy 211
Embracing tensions throughout crises: The case of an Italian university hospital during the COVID-19 pandemic 210
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 210
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 209
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 208
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 206
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 205
A prospective survey of febrile events in hematological malignancies. 201
PET con FDG nella dialisi peritoneale: le prospettive attuali e future 199
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 199
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. 198
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 197
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 197
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 196
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 195
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 194
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 193
Biopsy for suspected spondylodiscitis. 193
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 193
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies 192
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 191
Burkholderia cepacia infection in an infant affected by renal osteodystrophy 191
Advances in the therapy of bacterial bloodstream infections 191
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 190
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 190
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 190
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 189
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 189
Plasmodium falciparum malaria in migrants who transited Libya - Where did they contract malaria? 188
Impact of preoperative infection on outcome after liver transplantation 188
Schistosoma mansoni eggs in spleen and lungs, mimicking other diseases 188
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 187
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 187
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 187
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 186
Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, study 185
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 185
Bloodstream infections in patients with liver cirrhosis 185
Classification performance for covid patient prognosis from automatic ai segmentation—a single-center study 185
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 183
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 183
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 183
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 182
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 182
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study 181
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 181
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. 181
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 181
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues 180
Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. 180
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 180
Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study 179
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 179
Totale 26.006
Categoria #
all - tutte 213.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.067 0 0 0 0 0 0 0 0 0 358 282 1.427
2021/20227.345 581 286 419 581 661 385 244 583 324 744 1.338 1.199
2022/20237.557 756 993 392 990 564 543 257 511 1.326 272 549 404
2023/20243.610 243 420 231 349 311 569 283 280 185 307 208 224
2024/202513.882 557 1.680 1.128 1.095 1.837 738 1.080 544 350 987 1.128 2.758
2025/202632.344 3.115 3.533 2.952 2.707 3.078 2.991 4.567 1.412 6.055 1.934 0 0
Totale 80.423